Araştırma Makalesi

SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS

Cilt: 89 Sayı: 2 13 Mayıs 2026
PDF İndir
EN

SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS

Öz

Objective: This study aimed to evaluate the safety of percutaneous nephrolithotomy (PNL) following normalization of procalcitonin (PCT) levels in kidney stone patients with recurrent urinary tract infections (rUTIs) and assess the diagnostic performance of PCT in predicting postoperative infective complications.

Materials and Methods: A prospective cohort study was conducted between January 2020 and December 2024, including 29 kidney stone patients with a history of rUTI and persistent infection despite multiple antibiotic regimens. PNL was performed after normalization of serum PCT levels (<0.25 ng/mL). PCT levels were measured preoperatively and on postoperative day 1. The primary endpoint was the development of postoperative infective complications (composite of fever >38.5°C, PCT >2.0 ng/mL with clinical signs of infection, or positive blood culture); secondary endpoints included overall complication rate, stone-free rate, and length of hospital stay. The diagnostic performance of PCT was evaluated using ROC curve analysis.

Results: The mean age was 48.1±14.4 years, with 51.7% male patients. The average stone size was 31.1±14.1 mm. extendedspectrum betalactamase (ESBL)-producing E. coli was the most common preoperative pathogen (72.4%). Preoperative PCT median value was 0.06 ng/mL (range 0.01-0.24), with all patients within normal limits. All patients underwent successful PNL (mean operative time: 78.5±15.2 minutes). Postoperatively, infectious complications occurred in 3 patients (10.3%), with no cases of sepsis or septic shock. ROC analysis revealed an AUC of 0.887 (95% CI: 0.743–1.000, p=0.032), with an optimal cut-off value of 1.5 ng/mL (sensitivity: 100%, specificity: 89.3%). The stone-free rate was 55.2%, and the mean hospital stay was 2.7±1.04 days.

Conclusion: PNL guided by PCT is a safe and effective treatment in patients with rUTI. PCT is a valuable biomarker for predicting postoperative infections and supporting surgical decision-making in high-risk patients.

Anahtar Kelimeler

Kaynakça

  1. Hou H, Yang J, Han Z, Zhang X, Tang X, Chen T. Predictive values of the SOFA score and procalcitonin for septic shock after percutaneous nephrolithotomy. Urolithiasis 2022;50(6):729-35. google scholar
  2. Lan S, Liu B, Xie S, Yang C. Risk factors of systemic inflammatory response syndrome after minimally invasive percutaneous nephrolithotomy with a controlled irrigation pressure. BMC Urol 2024;24(1):287. google scholar
  3. Jung CE, Brubaker L. Postoperative urinary tract infection after urogynecologic surgery: Timing and uropathogens. Int Urogynecol J 2020;31(8):1621-6. google scholar
  4. García-Tello A et al. Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: Development of a clinical decision-making nomogram. Scand J Urol 2018;52(1):70-5. google scholar
  5. Ripa F, Cerrato C, Tandoğdu Z, Seitz C, Montanari E, Choong S, et al. Clinical significance of stone culture during endourological procedures in predicting post-operative urinary sepsis: should it be a standard of care—evidence from a systematic review and metaanalysis from EAU section of Urolithiasis (EULIS). World J Urol 2024;42(1):614. google scholar
  6. Zheng J, Guo Q, Yue G, Dou S, Zeng X, He T, et al. Is it necessary for patients with a positive urine culture to achieve a negative result after antimicrobial treatment before undergoing percutaneous nephrolithotomy? World J Urol 2025;43(1):131. google scholar
  7. Qi T, Lai C, Li Y, Chen X, Jin X. The predictive and diagnostic ability of IL-6 for postoperative urosepsis in patients undergoing percutaneous nephrolithotomy. Urolithiasis 2021;49(4):367-75. google scholar
  8. Canat HL, Can O, Atalay HA, Akkaş F, Ötünçtemur A. Procalcitonin as an early indicator of urosepsis following prostate biopsy. The Aging Male 2020;23(5):431-6. google scholar

Ayrıntılar

Birincil Dil

İngilizce

Konular

Üroloji

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

13 Mayıs 2026

Gönderilme Tarihi

10 Ekim 2025

Kabul Tarihi

1 Nisan 2026

Yayımlandığı Sayı

Yıl 2026 Cilt: 89 Sayı: 2

Kaynak Göster

APA
Bozkurt, O., Anıl, H., Aytekin, C., Kartal, S. B., Başaranoğlu, M., & Şener, N. (2026). SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS. Journal of Istanbul Faculty of Medicine, 89(2), 116-122. https://doi.org/10.26650/IUITFD.1800727
AMA
1.Bozkurt O, Anıl H, Aytekin C, Kartal SB, Başaranoğlu M, Şener N. SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS. İst Tıp Fak Derg. 2026;89(2):116-122. doi:10.26650/IUITFD.1800727
Chicago
Bozkurt, Osman, Hakan Anıl, Cuma Aytekin, Süleyman Barış Kartal, Mert Başaranoğlu, ve Nevzat Şener. 2026. “SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS”. Journal of Istanbul Faculty of Medicine 89 (2): 116-22. https://doi.org/10.26650/IUITFD.1800727.
EndNote
Bozkurt O, Anıl H, Aytekin C, Kartal SB, Başaranoğlu M, Şener N (01 Mayıs 2026) SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS. Journal of Istanbul Faculty of Medicine 89 2 116–122.
IEEE
[1]O. Bozkurt, H. Anıl, C. Aytekin, S. B. Kartal, M. Başaranoğlu, ve N. Şener, “SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS”, İst Tıp Fak Derg, c. 89, sy 2, ss. 116–122, May. 2026, doi: 10.26650/IUITFD.1800727.
ISNAD
Bozkurt, Osman - Anıl, Hakan - Aytekin, Cuma - Kartal, Süleyman Barış - Başaranoğlu, Mert - Şener, Nevzat. “SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS”. Journal of Istanbul Faculty of Medicine 89/2 (01 Mayıs 2026): 116-122. https://doi.org/10.26650/IUITFD.1800727.
JAMA
1.Bozkurt O, Anıl H, Aytekin C, Kartal SB, Başaranoğlu M, Şener N. SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS. İst Tıp Fak Derg. 2026;89:116–122.
MLA
Bozkurt, Osman, vd. “SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS”. Journal of Istanbul Faculty of Medicine, c. 89, sy 2, Mayıs 2026, ss. 116-22, doi:10.26650/IUITFD.1800727.
Vancouver
1.Osman Bozkurt, Hakan Anıl, Cuma Aytekin, Süleyman Barış Kartal, Mert Başaranoğlu, Nevzat Şener. SAFETY OF PROCALCITONIN-GUIDED PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONE PATIENTS WITH RECURRENT URINARY TRACT INFECTION AND ITS PERFORMANCE IN PREDICTING INFECTIOUS COMPLICATIONS. İst Tıp Fak Derg. 01 Mayıs 2026;89(2):116-22. doi:10.26650/IUITFD.1800727

Contact information and address

Addressi: İ.Ü. İstanbul Tıp Fakültesi Dekanlığı, Turgut Özal Cad. 34093 Çapa, Fatih, İstanbul, TÜRKİYE

Email: itfdergisi@istanbul.edu.tr

Phone: +90 212 414 21 61